Venrock Healthcare Capital Partners III, L.P. - Jan 3, 2024 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
10%+ Owner
Signature
Venrock Healthcare Capital Partners III, L.P., By: VHCP Management III, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Stock symbol
KALV
Transactions as of
Jan 3, 2024
Transactions value $
$720,543
Form type
4
Date filed
1/5/2024, 04:13 PM
Previous filing
Dec 29, 2023
Next filing
Jan 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALV Common Stock Purchase $215K +17.6K +0.43% $12.20 4.11M Jan 3, 2024 By Funds F1, F2, F3
transaction KALV Common Stock Purchase $506K +41.8K +1.02% $12.11 4.15M Jan 4, 2024 By Funds F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.08 to $12.24 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 Consists of (i) 895,571 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 89,587 shares held by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3"); and (iii) 3,125,178 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").
F3 VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCPEG and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the voting members of VHCPM3 and VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPM3, VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.
F4 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.91 to $12.17 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F5 Consists of (i) 906,551 shares held by VHCP3; (ii) 90,687 shares held by VHCP Co-3; and (iii) 3,154,862 shares held by VHCP EG.